Preview Mode Links will not work in preview mode

Jun 10, 2025

Featuring perspectives from Dr Jessica J Lin and Dr Joel W Neal, including the following topics:

  • Introduction: Actionable Genomic Alterations (0:00)
  • ALK (9:49)
  • ROS1 (22:22)
  • HER2 (31:00)
  • RET (38:52)
  • NTRK (45:30)
  • MET (46:31)
  • Novel Targeted Strategies (49:09)
  • BRAF (54:19)
  • KRAS G12C (55:38)

CME information and select...


Jun 8, 2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | Faculty Presentation 2: Therapeutic Approaches Targeting HER2, MET, BRAF and KRAS G12C — Joel W Neal, MD, PhD

CME information and select...


Jun 8, 2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | Faculty Presentation 1: Therapeutic Approaches Targeting ALK, ROS1, RET, TRK and NRG1 — Jessica J Lin, MD

CME information and select...


May 18, 2025

Featuring perspectives from Dr Ramaswamy Govindan and Dr Stephen V Liu, including the following topics:

  • Introduction (0:00)
  • Management of Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) without a Targetable Mutation — Dr Govindan (4:04)
  • First- and Later-Line Therapy for Metastatic NSCLC without a Targetable Mutation...


Apr 20, 2025

Featuring perspectives from Dr Jonathan Goldman and Dr Natasha B Leighl, including the following topics:

  • Introduction (0:00)
  • Current Management of Nonmetastatic and Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) — Prof Leighl (1:42)
  • Promising Novel Agents in Clinical Development; EGFR Exon 20...